ER Reactivation Therapy for Breast Cancer

NCT02188745 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: 17B-estradiol
DRUG: Letrozole
DRUG: Anastrozole
DRUG: Exemestane

Sponsor

Dartmouth-Hitchcock Medical Center